News
EDT Cathie Wood’s ARK Investment buys 191.5K shares of 10x Genomics (TXG) todayStay Ahead of the Market: Discover outperforming stocks ...
Barclays analyst Luke Sergott lowered the firm’s price target on 10x Genomics (TXG) to $12 from $15 and keeps an Overweight rating on the ...
StockStory.org on MSN1d
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...
StockStory.org on MSN1d
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services StocksAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...
Cactus 2.9.7 is available in the following forms: Docker Image: quay.io/comparative-genomics-toolkit/cactus:v2.9.7 GPU-accelerated Docker Image: quay.io/comparative ...
The US Single-Cell Analysis Market is projected to reach US$2,695.3 million by 2029 from an estimated US$1,378.6 million in 2024, at a CAGR ...
Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo.
DUBLIN and SAN DIEGO, March 27, 2025 /PRNewswire/ -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company improving and reducing ...
License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities DUBLIN and SAN DIEGO, March 27, 2025 /PRNewswire/ -- ERS ...
DUBLIN and SAN DIEGO, March 27, 2025 /PRNewswire/ -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company improving and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results